Company intelligence / Profile preview

Biotecom

Chile

Ownership: Private
Development stage: Other

Overview

Biotecom is a Chile-based biotechnology company (founded 2013) that distributes and produces molecular diagnostics, kits, and reagents for human, veterinary, and agri-food sectors, supplying hospitals, clinics, and laboratories and acting as a local channel for international diagnostic technologies, including rapid molecular COVID-19 tests.[1][4][5][6]

Therapeutic areas: OtherInfectious Diseases
Modalities: DeviceDiagnostic test
Industry: Molecular Diagnostics

Partnerships

Sense Biodetection (distribution of Veros Covid-19 molecular testing platform in Chile)[6]

Beyond the preview

Go deeper on Biotecom.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biotecom.

Explore the full profile